SLC41A2-ANAPC7 Fusion FISH Probe
The SLC41A2-ANAPC7 Fusion FISH Probe is used to confirm a fusion of the SLC41A2 and ANAPC7 genes. The fusion of the SLC41A2 and ANAPC7 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC41A2-ANAPC7-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC41A2-ANAPC7-20-AQAQ | 20 (40 μL) | 200 μL |
|
ANAPC7 Gene Summary
This gene encodes a tetratricopeptide repeat containing component of the anaphase promoting complex/cyclosome (APC/C), a large E3 ubiquitin ligase that controls cell cycle progression by targeting a number of cell cycle regulators such as B-type cyclins for 26S proteasome-mediated degradation through ubiquitination. The encoded protein is required for proper protein ubiquitination function of APC/C and for the interaction of APC/C with certain transcription coactivators. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
Gene Name: Anaphase Promoting Complex Subunit 7
Chromosome: CHR12: 110810704 -110841535
Locus: 12q24.11
SLC41A2 Gene Summary
The Solute Carrier Family 41 Member 2 (SLC41A2) gene is located on chr12 :105197274-105322472 at 12q23.3.
Gene Name: Solute Carrier Family 41 Member 2
Chromosome: CHR12: 105197274 -105322472
Locus: 12q23.3
Gene Diseases
The SLC41A2 ANAPC7 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|